Virtu Financial LLC Coherus Bio Sciences, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$2.02 - $3.14 $79,117 - $122,984	39,167 New	39,167 $94,000
Q2 2023 Jul 27, 2023	BUY	$3.79 - $8.3 $147,889 - $323,874	39,021 New	39,021 $167,000
Q2 2018 Jul 30, 2018	SELL	$10.25 - $17.45 $106,743 - $181,724	-10,414 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$10.25 - $17.45 $71,463 - $121,661	-6,972 Reduced 40.1%	10,414 $146,000
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $158,212 - $238,188	17,386 New	17,386 $192,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.